Metraipolis › archive › dc_ad8400d583df

Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304967
DOI
10.3390/ph18111723
License (as archived)
solo-consultazione
Archived
2026-11-08T14:27:31.126Z
SHA-256 of the archived text
7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7
Stable URL of this page
https://metraipolis.com/documento/dc_ad8400d583df

How to cite

Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967 — Europe PMC (en), https://europepmc.org/article/MED/41304967 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad8400d583df (Metraipolis archive dc_ad8400d583df, sha256 7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7)
BibTeX
@misc{dcad8400d583df,
  title = {Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases — Europe PMC PMID:41304967},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304967},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad8400d583df; sha256 7550442f042a69a1c03109deeb7c3c9b81a663fe58a5e51fcacc7038539c62d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304967. Agents can read the archived copy with the MCP tool read_document.